Standout Papers

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice 2021 2026 2022 2024194
  1. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice (2021)
    Eriya Kenjo, Hiroyuki Hozumi et al. Nature Communications

Immediate Impact

9 by Nobel laureates 8 from Science/Nature 88 standout
Sub-graph 1 of 18

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Rapid in silico directed evolution by a protein language model with EVOLVEpro
2024 StandoutScience
45 intermediate papers

Works of Eriya Kenjo being referenced

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
2021 Standout
Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
2016
and 7 more

Author Peers

Author Last Decade Papers Cites
Eriya Kenjo 577 213 66 109 10 782
Ju-Ock Nam 476 154 120 84 15 799
Ethlinn V.B. van Gaal 675 317 59 255 14 939
Sushmita Chatterjee 574 124 87 108 18 774
Kameron V. Kilchrist 676 264 60 200 21 939
Anuradha Gullapalli 490 117 82 107 11 839
Anastasia K. Varanko 460 212 106 94 13 788
Laura I. Selby 555 246 42 213 8 786
Kelli M. Luginbuhl 371 239 47 91 12 672
Kevin Buyens 794 289 23 163 12 960
Rikke Vicki Benjaminsen 666 190 135 163 6 965

All Works

Loading papers...

Rankless by CCL
2026